March 29 (Reuters) - Uscom Ltd UCM.AX :
* NOTIFIED THAT ITS BP+ NON- INVASIVE CENTRAL BLOOD PRESSURE MONITOR, ENTERED FINAL REVIEW PHASE OF NMPA REGULATORY APPROVAL
* FINAL NMPA APPROVAL IS EXPECTED TO BY APRIL TO AUGUST, 2021
March 29 (Reuters) - Uscom Ltd UCM.AX :
* NOTIFIED THAT ITS BP+ NON- INVASIVE CENTRAL BLOOD PRESSURE MONITOR, ENTERED FINAL REVIEW PHASE OF NMPA REGULATORY APPROVAL
* FINAL NMPA APPROVAL IS EXPECTED TO BY APRIL TO AUGUST, 2021